LWA
IPXL

Lenox Wealth Advisors’s Impax Laboratories, Inc. IPXL Stock Holding History

Lenox Wealth Advisors’s Portfolio IPXL Stock Details IPXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-37
Closed -$1K – 682
2018
Q1 		$1K Buy
+37
New +$726 ﹤0.01% 541

Lenox Wealth Advisors's IPXL Position: Q2 2018 in Review

Lenox Wealth Advisors sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 37 shares — an estimated $1K sold.

Lenox Wealth Advisors first reported a position in IPXL in Q1 2018 and held it in 1 quarter. The position peaked at $1K in Q1 2018. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.

  • Lenox Wealth Advisors reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
  • Lenox Wealth Advisors sold 37 Impax Laboratories, Inc. shares in Q2 2018, an estimated $1K.
  • Lenox Wealth Advisors first reported a position in Impax Laboratories, Inc. in Q1 2018 and held it in 1 quarter.
  • Lenox Wealth Advisors's Impax Laboratories, Inc. position peaked at $1K in Q1 2018.
  • 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.

Based on Lenox Wealth Advisors's 13F filing for Q2 2018, filed 16 Jul 2018.